English Deutsch 中文
  • Innovative Solutions
  • Expert Support and Knowledge
  • Reliable Cooperation
Menu Deutsch 中文

SciClone to Acquire NovaMed Pharma for ~$62 Million

Apr. 18, 2011

SciClone Pharmaceuticals of California has acquired Shanghai-based NovaMed Pharmaceuticals, a privately held company, for a price of ~$62 million. NovaMed is engaged in clinical development, registration and marketing of western drugs that are not yet launched in China and has collaborated with MNCs for their drugs’ launching in China. SciClone, though a US company, has its main market in China, which accounts for more than 90% of its annual sales.